Recerca > Càncer

Grup de recerca de biomarcadors en càncer (GReBiC)

Nombre de publicacions
495
Cercador de publicacions

  • Garcia-Alfonso P; Chaves M; Muñoz A; Salud A; García-Gonzalez M; Grávalos C; Massuti B; González-Flores E; Queralt B; López-Ladrón A; Losa F; Gómez MJ; Oltra A; Aranda E

    Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study

    Bmc Cancer 15 327-327. .

    [doi:10.1186/s12885-015-1293-y]

  • Martín M; Loibl S; von Minckwitz G; Morales S; Martinez N; Guerrero A; Anton A; Aktas B; Schoenegg W; Muñoz M; Garcia-Saenz JÁ; Gil M; Ramos M; Margeli M; Carrasco E; Liedtke C; Wachsmann G; Mehta K; De la Haba-Rodriguez JR

    Phase III Trial Evaluating the Addition of Bevacizumab to Endocrine Therapy As First-Line Treatment for Advanced Breast Cancer: The Letrozole/Fulvestrant and Avastin (LEA) Study

    Journal of Clinical Oncology 33 1045-1045. .

    [doi:10.1200/JCO.2014.57.2388]

  • Porcel JM; Hernández P; Martínez-Alonso M; Bielsa S; Salud A

    Accuracy of Fluorodeoxyglucose-PET Imaging for Differentiating Benign From Malignant Pleural Effusions A Meta-analysis

    Chest 147 502-512. .

    [doi:10.1378/chest.14-0820]

  • Porcel JM; Pardina M; Bielsa S; González A; Light RW

    Derivation and Validation of a CT Scan Scoring System for Discriminating Malignant From Benign Pleural Effusions

    Chest 147 513-519. .

    [doi:10.1378/chest.14-0013]

  • Feliu J; Salud A; Safont MJ; García-Girón C; Aparicio J; Losa F; Bosch C; Escudero P; Casado E; Jorge M; Bohn U; Pérez-Carrión R; Carmona A; Custodio AB; Maurel J

    Correlation of Hypertension and Proteinuria with Outcome in Elderly Bevacizumab-Treated Patients with Metastatic Colorectal Cancer

    PLOS ONE 10 -. .

    [doi:10.1371/journal.pone.0116527]

  • Bagüeste-Morán, P.; Bielsa, S.; Porcel, J.M.

    Contraceptive vaginal ring as a risk factor of pulmonary thromboembolism

    Revista De Patologia Respiratoria 18 42-43. .

  • Azzopardi M; Porcel JM; Koegelenberg CF; Gary Lee YC; Fysh ET

    Current Controversies in the Management of Malignant Pleural Effusions

    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE 35 723-731. .

    [doi:10.1055/s-0034-1395795]

  • Fernandez-Plana J; Pericay C; Quintero G; Alonso V; Salud A; Mendez M; Salgado M; Saigi E; Cirera L

    Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)

    Bmc Cancer 14 865-865. .

    [doi:10.1186/1471-2407-14-865]

  • Fernandez-Martos C; Brown G; Estevan R; Salud A; Montagut C; Maurel J; Safont MJ; Aparicio J; Feliu J; Vera R; Alonso V; Gallego J; Martin M; Pera M; Sierra E; Serra J; Delgado S; Roig JV; Santos J; Pericay C

    Preoperative Chemotherapy in Patients With Intermediate-Risk Rectal Adenocarcinoma Selected by High-Resolution Magnetic Resonance Imaging: The GEMCAD 0801 Phase II Multicenter Trial

    Oncologist 19 1042-1043. .

    [doi:10.1634/theoncologist.2014-0233]

  • Gomez-Martín, C.; Lopez-Rios, F.; Aparicio, J.; Barriuso, J.; García-Carbonero, R.; Pazo, R.; Rivera, F.; Salgado, M.; Salud, A.; Vázquez-Sequeiros, E.; Lordick, F.

    A critical review of HER2-positive gastric cancer evaluation and treatment: From trastuzumab, and beyond

    CANCER LETTERS 351 30-40. .

    [doi:10.1016/j.canlet.2014.05.019]

  • Bielsa S; Valencia H; Ruiz-González A; Esquerda A; Porcel JM

    Serum C-Reactive Protein as an Adjunct for Identifying Complicated Parapneumonic Effusions

    Lung 192 577-581. .

    [doi:10.1007/s00408-014-9606-5]

  • Feliu J; Salud A; Safont MJ; García-Girón C; Aparicio J; Vera R; Serra O; Casado E; Jorge M; Escudero P; Bosch C; Bohn U; Pérez-Carrión R; Carmona A; Martínez-Marín V; Maurel J

    First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study

    BRITISH JOURNAL OF CANCER 111 241-248. .

    [doi:10.1038/bjc.2014.346]